Back to top

BMY Reiterates by Cantor Fitzgerald -- Price Target Maintained at $54

BMY Reiterates by Cantor Fitzgerald -- Price Target Maintained at $54

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bristol Myers Squibb Company (BMY)